Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers

Proteomic signatures associated with clinical measures of more aggressive cancers could yield molecular clues as to disease drivers. Here, utilizing the Clinical Proteomic Tumor Analysis Consortium (CPTAC) mass-spectrometry-based proteomics datasets, we defined differentially expressed proteins and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncogene
Autors principals: Monsivais, Diana, Vasquez, Yasmin, Chen, Fengju, Zhang, Yiqun, Chandrashekar, Darshan S., Faver, John C., Masand, Ramya P., Scheurer, Michael E., Varambally, Sooryanarayana, Matzuk, Martin M., Creighton, Chad J.
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7981264/
https://ncbi.nlm.nih.gov/pubmed/33627787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-021-01681-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars